MedTrace Logo

Gemeprost Versus Dinoprostone in First Trimester Miscarriages

NCT05342467 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2025-06-11

No results posted yet for this study

Summary

Comparison between gemeprost and dinoprostone to evacuate first trimester miscarriages.

Conditions

  • Missed Abortion
  • Medical; Abortion, Fetus
  • Incomplete Abortion

Interventions

DRUG

Gemeprost 1 Mg Vaginal Pessary

Intravaginal gemeprost 1 mg inserted 3 hourly for maximum of 5 doses in 24 hours

DRUG

Dinoprostone 3 mg

Intravaginal dinoprostone 3 mg inserted 4 hourly for maximum of 3 doses in 24 hours

Sponsors & Collaborators

  • National University of Malaysia

    lead OTHER

Principal Investigators

  • Rahana Abd Rahman · National University of Malaysia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-11
Primary Completion
2024-10-28
Completion
2024-10-28

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05342467 on ClinicalTrials.gov